For in vitro diagnostic use. Others Elecsys Anti-HBc IgM IVD Elecsys® Anti-HBc IgM CPS_000438 07026811160 Anti-HBc IgM Elecsys E2G 300 Elecsys Anti-HBc IgM 07613336153932 Reagents, kits 300 tests cobas e 402/801 true 11820567122 Anti-HBc IgM Elecsys cobas e 100 Elecsys Anti-HBc IgM 04015630936915 Reagents, kits 100 tests cobas e 411/601/602 true 07026811190 Anti-HBc IgM Elecsys E2G 300 Elecsys Anti-HBc IgM 04015630939923 Reagents, kits 300 tests cobas e 402/801 true 11820567160 Anti-HBc IgM Elecsys cobas e 100 Elecsys Anti-HBc IgM 07613336154342 Reagents, kits 100 tests cobas e 411/601/602 true 07026811500 Elecsys Anti-HBc IgM en 2 FF000000074D7A0E FF0000000201260E 07026811160 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to hepatitis B core antigen (anti‑HBc IgM) in human serum or plasma (potassium EDTA, lithium heparin, sodium heparin, sodium citrate) in adult patients with symptoms of hepatitis or who may be at risk for hepatitis B (HBV) infection. The presence of anti‑HBc IgM, in conjunction with other laboratory results and clinical information, is indicative of acute or recent hepatitis B virus (HBV) infection. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11820567500 Elecsys Anti-HBc IgM en 21 FF00000004B7870E FF000000001D290E 11820567122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07026811500 Elecsys Anti-HBc IgM en 2 FF00000004459F0E FF00000000E8720E 07026811190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026811500 Elecsys Anti-HBc IgM en 3 FF00000004C6CC0E FF00000001A94E0E 07026811190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to the hepatitis B core antigen in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_11820567160_USA Elecsys Anti-HBc IgM en 8 FF00000001BDA20E FF0000000026510E 11820567160 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to hepatitis B core antigen (anti‑HBc IgM) in human serum or plasma (potassium EDTA, lithium heparin, sodium heparin, sodium citrate) in adult patients with symptoms of hepatitis or who may be at risk for hepatitis B (HBV) infection. The presence of anti‑HBc IgM, in conjunction with other laboratory results and clinical information, is indicative of acute or recent hepatitis B virus (HBV) infection. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 411 immunoassay analyzer. en ms_11820567160_USA Elecsys Anti-HBc IgM en 8 FF00000001BE400E FF000000007AFF0E 11820567160 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to hepatitis B core antigen (anti‑HBc IgM) in human serum or plasma (potassium EDTA, lithium heparin, sodium heparin, sodium citrate) in adult patients with symptoms of hepatitis or who may be at risk for hepatitis B (HBV) infection. The presence of anti‑HBc IgM, in conjunction with other laboratory results and clinical information, is indicative of acute or recent hepatitis B virus (HBV) infection. The immunoassay's performance has not been established for the monitoring of HBV disease or therapy. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 601 and cobas e 602 immunoassay analyzers. en